@article{6164f5bc0cb14bbb8af0d80640739e90,
title = "Pancreatic adenocarcinoma, version 2.2017: Clinical practice guidelines in Oncology",
abstract = "Ductal adenocarcinoma and its variants account for most pancreatic malignancies. High-quality multiphase imaging can help to preoperatively distinguish between patients eligible for resection with curative intent and those with unresect-able disease. Systemic therapy is used in the neoadjuvant or adjuvant pancreatic cancer setting, as well as in the management of locally advanced unresectable and metastatic disease. Clinical trials are critical for making progress in treatment of pancreatic cancer. The NCCN Guidelines for Pancreatic Adeno-carcinoma focus on diagnosis and treatment with systemic therapy, radiation therapy, and surgical resection.",
author = "Tempero, {Margaret A.} and Malafa, {Mokenge P.} and Mahmoud Al-Hawary and Horacio Asbun and Andrew Bain and Behrman, {Stephen W.} and {Al Benson}, B. and Ellen Binder and Cardin, {Dana B.} and Charles Cha and Chiorean, {E. Gabriela} and Vincent Chung and Brian Czito and Mary Dillhoff and Efrat Dotan and Ferrone, {Cristina R.} and Jeffrey Hardacre and Hawkins, {William G.} and Joseph Herman and Ko, {Andrew H.} and Srinadh Komanduri and Albert Koong and Noelle LoConte and Lowy, {Andrew M.} and Cassadie Moravek and Nakakura, {Eric K.} and O'Reilly, {Eileen M.} and Jorge Obando and Sushanth Reddy and Courtney Scaife and Sarah Thayer and Weekes, {Colin D.} and Wolff, {Robert A.} and Wolpin, {Brian M.} and Jennifer Burns and Susan Darlow",
note = "Publisher Copyright: {\textcopyright} JNCCN-Journal of the National Comprehensive Cancer Network.",
year = "2017",
month = aug,
doi = "10.6004/jnccn.2017.0131",
language = "English (US)",
volume = "15",
pages = "1028--1061",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Harborside Press",
number = "8",
}